ISCO
Price:
$0.14
Market Cap:
$1.12M
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cell...[Read more]
Industry
Biotechnology
IPO Date
2007-05-01
Stock Exchange
OTC
Ticker
ISCO
According to International Stem Cell Corporation’s latest financial reports and current stock price. The company's current ROE is 3.33%. This represents a change of -111.86% compared to the average of -28.08% of the last 4 quarters.
The mean historical ROE of International Stem Cell Corporation over the last ten years is -43.64%. The current 3.33% ROE has changed -107.63% with respect to the historical average. Over the past ten years (40 quarters), ISCO's ROE was at its highest in in the September 2017 quarter at 1.16%. The ROE was at its lowest in in the June 2016 quarter at -1111.91%.
Average
-43.64%
Median
-13.01%
Minimum
-294.04%
Maximum
150.42%
Discovering the peaks and valleys of International Stem Cell Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 838.53%
Maximum Annual ROE = 150.42%
Minimum Annual Increase = -1224.46%
Minimum Annual ROE = -294.04%
| Year | ROE | Change |
|---|---|---|
| 2024 | 5.32% | -104.59% |
| 2023 | -115.93% | -1224.46% |
| 2022 | 10.31% | -54.52% |
| 2021 | 22.67% | -65.38% |
| 2020 | 65.47% | -56.47% |
| 2019 | 150.42% | -279.07% |
| 2018 | -84.00% | -71.43% |
| 2017 | -294.04% | 838.53% |
| 2016 | -31.33% | -81.05% |
| 2015 | -165.31% | -95.75% |
The current ROE of International Stem Cell Corporation (ISCO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-33.43%
5-year avg
-2.43%
10-year avg
-43.64%
International Stem Cell Corporation’s ROE is greater than Biocure Technology Inc. (-17.50%), less than Evofem Biosciences, Inc. (7.90%), less than Chia Tai Enterprises International Limited (10.83%), less than Marizyme, Inc. (48.42%), less than Biomind Labs Inc. (3.21%), less than Biora Therapeutics, Inc. (12.18%), less than NovelStem International Corp. (39.17%), less than Unity Biotechnology, Inc. (0%), less than DATATRAK International, Inc. (353.64%), less than Vaccinex, Inc. (662.54%),
| Company | ROE | Market cap |
|---|---|---|
| -17.50% | $379.09K | |
| 7.90% | $1.51M | |
| 10.83% | $217.44M | |
| 48.42% | $39.54K | |
| 3.21% | $1.23M | |
| 12.18% | $994.99K | |
| 39.17% | $937.63K | |
| 0% | $965.60K | |
| 353.64% | $383.40K | |
| 662.54% | $1.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like International Stem Cell Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like International Stem Cell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is International Stem Cell Corporation's ROE?
How is the ROE calculated for International Stem Cell Corporation (ISCO)?
What is the highest ROE for International Stem Cell Corporation (ISCO)?
What is the 3-year average ROE for International Stem Cell Corporation (ISCO)?
What is the 5-year average ROE for International Stem Cell Corporation (ISCO)?
How does the current ROE for International Stem Cell Corporation (ISCO) compare to its historical average?